ResearcherClinica Universidad de NavarraNo recent work listed
Pablo Sala Elarre
Matched on OpenAlex author ID A5053829776. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2023.03.001↗
- Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse. Co-author DOI 10.3390/cancers11050606↗
- Omics Approaches in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers11081052↗
- Counterpoint: Weighing the Risks and Benefits of Neoadjuvant Therapy in Resectable Pancreatic Cancer. Neoadjuvant Therapy Should Not Be Used as Part of Standar… Co-author PMID 29447421↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenneth H. Yu · 2 shared papers, 2018–2019 · strength 0.25
- Mariano Ponz‐Sarvisé · 2 shared papers, 2019–2023 · strength 0.24
- Fernando Rotellar · 2 shared papers, 2019–2023 · strength 0.24
- A. Vilalta · 1 shared paper, 2023 · strength 0.16
- Iranzu González‐Borja · 1 shared paper, 2019 · strength 0.08
- Joaquín Fernández‐Irigoyen · 1 shared paper, 2019 · strength 0.08
- Antonio Viúdez · 1 shared paper, 2019 · strength 0.08
- Estefanía Carrasco‐García · 1 shared paper, 2019 · strength 0.08
- Ruth Vera · 1 shared paper, 2019 · strength 0.08
- Javier Rodríguez · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.